How big is the lateral flow assays market?

The global lateral flow assay market size was estimated at USD 10.17 billion in 2025 and is expected to reach USD 10.57 billion in 2026.

What is the lateral flow assays market growth?

The global lateral flow assay market is expected to reach USD 17.44 billion by 2033, growing at a compound annual growth rate of 7.41% from 2026 to 2033.

Which segment accounted for the largest lateral flow assays market share?

Clinical testing dominated the lateral flow assay market with a share of 74.20% in 2025. This is attributable to the increase in various chronic and infectious diseases globally.

Who are the key players in the lateral flow assays market?

Some key players operating in the lateral flow assays market include Abbott; Thermo Fisher Scientific, Inc.; F. Hoffmann-La Roche AG; Bio-Rad Laboratories, Inc.; bioMérieux SA; Quidel Corporation; Hologic, Inc.; QIAGEN; DH Life Sciences, LLC.; Siemens Healthineers

What are the factors driving the lateral flow assays market?

Key factors that are driving the lateral flow assays market growth include the increase in demand for point of care testing and the rising incidence of infectious diseases is anticipated to result in demand for lateral flow assays globally.